View by Specialty

Trending

Drinking more coffee and tea lowers the risk for developng multiple cardiometabolic disorders.
September 17, 2024
3 min read
Save

Drinking moderate amounts of caffeine may cut risk for multiple cardiometabolic diseases

Pediatric Neurology News

SPONSORED CONTENT
Save
SPONSORED CONTENT
June 08, 2023
4 min watch
Save

VIDEO: Psychosocial assessment may benefit pediatric patients with cerebral palsy

VIDEO: Psychosocial assessment may benefit pediatric patients with cerebral palsy

In this video, M. Wade Shrader, MD, discussed the impact of preoperative psychosocial assessment on length of stay in pediatric patients with cerebral palsy undergoing hip reconstruction or spinal fusion.

SPONSORED CONTENT
June 07, 2023
3 min watch
Save

VIDEO: Improved pain, sitting cited as goals of spine surgery for cerebral palsy scoliosis

VIDEO: Improved pain, sitting cited as goals of spine surgery for cerebral palsy scoliosis

In this video, Suken A. Shah, MD, discussed results that showed caregivers and surgeons primarily seek spine surgery for children with cerebral palsy scoliosis to improve pain and sitting ability, as well as to prevent complications.

Trending

Drinking more coffee and tea lowers the risk for developng multiple cardiometabolic disorders.
September 17, 2024
3 min read
Save

Drinking moderate amounts of caffeine may cut risk for multiple cardiometabolic diseases

SPONSORED CONTENT
June 07, 2023
3 min watch
Save

VIDEO: Children with cerebral palsy have abnormal foot pressure, study finds

VIDEO: Children with cerebral palsy have abnormal foot pressure, study finds

In this video, M. Wade Shrader, MD, discussed results that showed children with cerebral palsy have abnormal foot pressure compared with that of children without cerebral palsy.

SPONSORED CONTENT
June 06, 2023
3 min read
Save

Increased education, clearer guidelines needed on melatonin use in children

Increased education, clearer guidelines needed on melatonin use in children

INDIANAPOLIS — In a session on melatonin use in children, Judith Owens, MD, MPH, aimed to pique discussion among attendees about the challenges of talking with parents and families about the supplement’s use in this patient population.

SPONSORED CONTENT
June 06, 2023
1 min read
Save

Cortisol levels in last trimester may predict infant sleep onset at 7 months

Cortisol levels in last trimester may predict infant sleep onset at 7 months

INDIANAPOLIS — Newborns with higher levels of hair cortisol, a measure of fetal cortisol in the last trimester of pregnancy, were more likely to have delayed sleep onset at age 7 months, according to preliminary research.

SPONSORED CONTENT
June 01, 2023
2 min read
Save

Rise in pediatric intracranial infections coincided with spike in respiratory viruses

Rise in pediatric intracranial infections coincided with spike in respiratory viruses

There were increases in rare pediatric intracranial infections over the past 3 years that coincided with notable spikes in respiratory viruses, although the infections remained rare, according to two reports published Thursday in MMWR.

SPONSORED CONTENT
May 03, 2023
1 min read
Save

Therapeutic hypothermia not effective for younger newborns, study finds

Therapeutic hypothermia not effective for younger newborns, study finds

WASHINGTON — The only evidence-based therapy for neonatal encephalopathy is not effective for younger newborns, researchers reported at the Pediatric Academic Societies Meeting.

SPONSORED CONTENT
April 21, 2023
1 min read
Save

Increases in myelin, white matter reported at 6 months with Canavan disease gene therapy

Increases in myelin, white matter reported at 6 months with Canavan disease gene therapy

Myrtelle Inc. has reported promising 6-month trial data for a recombinant adeno-associated virus vector-based investigational gene therapy for Canavan disease.

SPONSORED CONTENT
April 17, 2023
2 min read
Save

Avalglucosidase alfa maintains respiratory function, endurance in late-onset Pompe disease

Avalglucosidase alfa maintains respiratory function, endurance in late-onset Pompe disease

Continuous treatment with avalglucosidase alfa, or after a switch from alglucosidase alfa, maintained respiratory function and functional endurance in patients with late-onset Pompe disease, with no new safety concerns reported.

SPONSORED CONTENT
April 12, 2023
1 min read
Save

FDA grants fast track designation for novel Duchenne muscular dystrophy gene therapy

FDA grants fast track designation for novel Duchenne muscular dystrophy gene therapy

Regenxbio Inc. announced that the FDA has granted fast track designation for RGX-202, a one-time gene therapy for treatment of Duchenne muscular dystrophy.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails